Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian V Hernandez

Showing results (1-10 of 261) with videos related to

Pageof 27
Sort By:
Archives of Internal Medicine|September 26, 2012
No place for novel oral anticoagulants in current treatment of acute coronary syndromesAdrian V Hernandez
European Heart Journal|November 27, 2013
Serelaxin: insights into its haemodynamic, biochemical, and clinical effects in acute heart failureAdrian V Hernandez
Archives of Internal Medicine|January 11, 2012
Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trialsKen Uchino, Adrian V Hernandez
Clinical Cardiology|January 16, 2025
Prognostic Value of Frailty in Patients With Takotsubo CardiomyopathyCarlos Diaz-Arocutipa, Adrian V Hernandez
JAMA|November 23, 2021
Risk of N-Nitrosodimethylamine (NMDA) Formation With Ranitidine-ReplyC Michael White, Adrian V Hernandez
Journal of Clinical Pharmacology|June 13, 2020
Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% DangerousC Michael White, Adrian V Hernandez
JAMA|June 28, 2021
Ranitidine and Risk of N-Nitrosodimethylamine (NDMA) FormationC Michael White, Adrian V Hernandez
Chest|October 7, 2018
ResponseMonica Khunger, Adrian V Hernandez, Vamsidhar Velcheti
Cleveland Clinic Journal of Medicine|July 4, 2008
Meta-analysis: Its strengths and limitationsEsteban Walker, Adrian V Hernandez, Michael W Kattan
Hematological Oncology|March 28, 2019
Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtypeHasan Abuamsha, Amer N Kadri, Adrian V Hernandez
Pageof 27

Showing results (1-10 of 261) with videos related to

Sort By:
Pageof 27
Archives of Internal Medicine|September 26, 2012
No place for novel oral anticoagulants in current treatment of acute coronary syndromesAdrian V Hernandez
European Heart Journal|November 27, 2013
Serelaxin: insights into its haemodynamic, biochemical, and clinical effects in acute heart failureAdrian V Hernandez
Archives of Internal Medicine|January 11, 2012
Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trialsKen Uchino, Adrian V Hernandez
Clinical Cardiology|January 16, 2025
Prognostic Value of Frailty in Patients With Takotsubo CardiomyopathyCarlos Diaz-Arocutipa, Adrian V Hernandez
JAMA|November 23, 2021
Risk of N-Nitrosodimethylamine (NMDA) Formation With Ranitidine-ReplyC Michael White, Adrian V Hernandez
Journal of Clinical Pharmacology|June 13, 2020
Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% DangerousC Michael White, Adrian V Hernandez
JAMA|June 28, 2021
Ranitidine and Risk of N-Nitrosodimethylamine (NDMA) FormationC Michael White, Adrian V Hernandez
Chest|October 7, 2018
ResponseMonica Khunger, Adrian V Hernandez, Vamsidhar Velcheti
Cleveland Clinic Journal of Medicine|July 4, 2008
Meta-analysis: Its strengths and limitationsEsteban Walker, Adrian V Hernandez, Michael W Kattan
Hematological Oncology|March 28, 2019
Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtypeHasan Abuamsha, Amer N Kadri, Adrian V Hernandez
Pageof 27